VIEN GUT MODEL
Integrated Outpatient Care for Complex Chronic Multimorbidity
Integrated Outpatient Care for Complex Multimorbid Chronic Diseases [1]
Part A — Foundations of the Vien Gut Model Academic Series [1]
From gaps to an operable structure [1]
Vien Gut Model — First Systematic Collection of Academic Documents — March 2026 [1]
Ho Chi Minh City, Vietnam [1]
DOCUMENT A.1 — EBM REFERENCE FRAMEWORK: WHAT + HOW + DATA-TO-OPERATE [4]
*From gaps to an operable structure* [4]
Nguyễn Đình Quang — Vien Gut Model [4]
March 2026 — Ho Chi Minh City, Vietnam [4]
Document A.1 stems from a practical observation: well-trained doctors, despite having full international guidelines, still face difficulties when treating complex chronic multimorbid patients. [4] The cause does not lie in the quality of the guidelines, but in the fact that guidelines are only one of three layers needed to operate integrated care. [4] The remaining two layers — HOW and DATA-to-operate — do not exist in the current EBM chain as systematically designed components. [4]
The document analyzes the EBM chain through 8 steps — from basic research to guideline development — and points out that the first 7 steps perform excellently for single diseases, but the 8th step (clinical application) is the breakpoint when the subject is a complex chronic multimorbid patient. [5]
| Cause [6] | Description [6] |
|---|---|
| Single-disease guidelines | RCTs exclude severe multimorbid patients — evidence is generated on “clean” populations |
| No integration mechanism | No guideline describes how to coordinate when a drug good for one axis harms another |
| No coordinator | EBM chain ends at “the doctor applying the guideline” — no one is identified as having overall responsibility |
| No longitudinal data | Chronic multimorbidity requires time-series data — guidelines rely only on cross-sectional views |
The EBM chain has a self-improving feedback loop: discovering limitations → new research → updated guidelines. [6] This loop performs excellently for WHAT (guidelines get better), but does not create HOW. [6] Structural reason: HOW is not a product of RCTs or basic research — HOW is a product of structured integrated clinical practice over a long period. [6] The EBM chain was not designed to create this layer. [6]
Mô hình Viện Gút does not replace EBM — it completes EBM by adding the two missing layers. [7] These three layers are inseparable — they form a single integrated framework: [7]
| Layer [7, 8] | Content [7, 8] |
|---|---|
| WHAT | Guidelines and evidence — already exist, need to be reorganized into a clinical priority map for each specific multimorbid patient. The challenge is not a lack of guidelines but organizing multiple single-disease guidelines into a unified plan. |
| HOW | Structured clinical operations — the missing layer in EBM. Specifically describes: who does what, when, based on what threshold, response SLA duration, and when to activate safety valves. Developed by Viện Gút over 18 years of practice. |
| DATA-to-operate | Longitudinal data triggering decisions — not research data but clinical data collected in a structured way, connecting WHAT to HOW in real-time. |
| Missing Layer? [8, 9] | Consequence [8, 9] | Clinical Illustration [8, 9] |
|---|---|---|
| Missing HOW | WHAT stays on paper, not translated into integrated action | Gout + CKD G4 + heart failure: 3 conflicting guidelines, no coordinator |
| Missing DATA-to-operate | HOW operates blindly, decisions based on single snapshots | Failure to see eGFR sliding down → late activation of safety valve |
| Missing WHAT | HOW + DATA operate without standards | Does not happen in Mô hình VG — WHAT is always kept from guidelines |
The WHAT–HOW–DATA-to-operate framework is the operational foundation for all four verification targets — none can be achieved with WHAT alone: [9]
| Target [9, 10] | WHAT (Guideline) [9, 10] | HOW (Operations) [9, 10] | DATA-to-operate [9, 10] |
|---|---|---|---|
| C.1 Crystal-free | T2T urate lowering (ACR/EULAR) | Phasing, safe renal-hepatic polypharmacy management | Longitudinal US caliper mm² monitoring of urate crystals |
| C.2 Kidney Preservation | KDIGO 2024 CKD management | Resolving conflicts between urate-lowering drugs and kidney function | Time-series eGFR, creatinine, albuminuria |
| C.3 Reduced Heart Decompensation | ESC 2021 heart failure | Balancing diuretics–urate lowering–kidney protection | BNP/NT-proBNP, EF, emergency hospitalization frequency |
| C.4 Liver Cirrhosis Re-compensation | EASL 2018 decompensated cirrhosis | Polypharmacy management to avoid hepatotoxicity, coagulation monitoring | Child–Pugh, MELD, Fibroscan, time-series albumin |
A.1 is the central theoretical framework of Part A. [10] It lays the foundation for the entire document series by pointing out the structural breakpoint in the EBM chain and presenting the three-layer framework as a solution. [10] Position: A.0 (architectural statement) → A.1 (EBM framework — this document) → A.2 (definition of the three layers) → A.3 (gap evidence) → A.4–A.5 (terminology). [10] Part B implements HOW + DATA-to-operate into operational procedures. Part C verifies results on target organs. [10]
The EBM chain is a great achievement of modern medicine — but it was designed according to single-disease logic. [11] When the subject is a complex chronic multimorbid patient (4–7 severe diseases simultaneously, multiple pathological spirals, multiple guideline conflicts), the EBM chain encounters a structural breakpoint at the application step. [11] The WHAT–HOW–DATA-to-operate framework of the Mô hình Viện Gút is the result of systematization from 18 years of integrated clinical practice — filling the structural gaps that the EBM chain was not designed to create. [11]
*Vien Gut Model does not replace EBM — it completes EBM by adding the two missing layers (HOW and DATA-to-operate) and verifying outcomes on four target organs.* [11]
REFERENCES (abridged) [12, 13]
[1] Sackett DL, et al. BMJ. 1996;312(7023):71–72.
[2] Barnett K, et al. Lancet. 2012;380(9836):37–43.
[3] Wagner EH, et al. Health Aff. 2001;20(6):64–78.
[6] Tinetti ME, et al. N Engl J Med. 2004;351(27):2870–2874.
[8] WHO. Framework on Integrated, People-centred Health Services. Geneva: WHO; 2016.
[10] FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 ACR Guideline for Gout.
[11] KDIGO. 2024 Clinical Practice Guideline for CKD.
[12] McDonagh TA, et al. 2021 ESC Guidelines for heart failure.
[13] EASL. Clinical Practice Guidelines for decompensated cirrhosis. J Hepatol. 2018.
*Note: Full list (13 documents): see full text of A.1.* [13]
*Viện Gút is ready to share the entire model with the international medical community as a public asset, serving the goal of improving care for complex chronic multimorbid patients in 129 low- and middle-income countries.* [13]
Electronic information portal providing specialized services (medicine and science & technology) of Vien Gut Company Limited. Compliant with Article 24, Clause 2 of Decree No. 147/2024/ND-CP, GDPR, and CCPA/CPRA.
Navigation
Policy